Purchase this article with an account.
Kwangsic Joo, Sang Jun Park, Young Mi Na, Hye kyoung Hong, Yewon Choi, Jung Eun Lee, Hyuncheol Kim, Kyu Hyung Park, Ho Min Kim, Jae Yong Chung, Se Joon Woo; The role of Fc portion in the intravitreous half-life of anti-VEGF drugs. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1202.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To identify the role of Fc portion in intraocular pharmacokinetics (PK) of protein drugs using the two identical protein drugs except the Fc portion
We generated a new VEGF-Trap without Fc portion (small VEGF-Trap, MW=100kDa) by replacing the Fc portion of conventional VEGF-Trap (MW=145kDa) with a dimerized coiled-coil domain. A total of 42 eyes of 42 rabbits were injected intravitreally with VEGF-Trap (n=21) and small VEGF-Trap (n=21). Eyes were harvested at 6 time points (1h and 1, 2, 4, 14 and 30 days after injections). The concentrations of VEGF-Trap and small VEGF-Trap in the vitreous, aqueous humor, and retina/choroid were measured by an indirect enzyme-linked immunosorbent assay, and pharmacokinetic properties of the drugs were analyzed under hypothetical compartment model system. One-compartment model was applied as the final model for the vitreous whereas two-compartment model was applied for aqueous humor and retina/choroid tissue.
In all three tissues, the maximum concentrations of both small VEGF-Trap and VEGF-Trap were observed 1 hour after intravitreal injection. The estimated half-lives of small VEGF-Trap in the vitreous and retina/choroid were 1.4 and 2.3 times longer (145.02 and 102.12 hours, respectively) than those of VEGF-Trap (103.99 and 44.42 hours, respectively). The total exposure of small VEGF-Trap in the aqueous humor and retina/choroid were approximately 13.2% and 39%, respectively, of the vitreous exposure whereas VEGF-Trap concentrations were approximately 25.2% and 26.2%, indicating that small VEGF-Trap show a preference for the posterior excretion.
The vitreous and retina/choroid half-lives of small VEGF-Trap are significantly longer than that of VEGF-Trap in rabbit eyes despite the lower molecular weight of small VEGF-Trap. This suggests that Fc receptors in ocular tissues contribute to the elimination of anti-VEGF drugs. Truncation or mutation of Fc portion can partially prolong the residence time of VEGF-Trap and have the possibility of reducing the number of VEGF-Trap injections.
This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.
Protein structures of VEGF-Trap and truncated VEGF proteins. (A) Small VEGF-Trap contains a dimerized coiled coil domain instead of Fc domain of VEGF-Trap. (B) A protein 3D structure of small VEGF-Trap was predicted by I-TASSER.
Small VEGF-Trap concentration in the eye of rabbit. Points represent observed concentrations and lines represent estimated concentrations by models
This PDF is available to Subscribers Only